SCHEMBL124691

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL169712	0.91	BTK (0.50)	BTKTNK2RIPK1P2RX4PTGDR2
	SCHEMBL122380	0.91	BTK (0.53)	BTKTNK2RIPK1FYNDHFR
	SCHEMBL125087	0.90	BTK (0.53)	BTKTNK2RIPK1FYNDHFR
	SCHEMBL122657	0.89	BTK (0.48)	BTKTNK2RIPK1EGFRERBB2
	SCHEMBL169188	0.89	BTK (0.52)	BTKTNK2RIPK1PIK3CD
	SCHEMBL170174	0.88	BTK (0.52)	BTKTNK2RIPK1FYNDHFR
	SCHEMBL167427	0.86	BTK (0.51)	BTKTNK2RIPK1FYNDHFR
	SCHEMBL169866	0.86	BTK (0.50)	BTKTNK2RIPK1FYNKDR
	SCHEMBL169039	0.84	BTK (0.50)	BTKTNK2RIPK1FYNPIK3CD
	SCHEMBL169241	0.84	BTK (0.51)	BTKTNK2RIPK1FYNFGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.